Scalable primate pluripotent stem cell aggregate suspension culture
US11015170B2 · kind B2 · utility
0Cited by
17References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 26, 2018 |
| Grant date | May 25, 2021 |
| Priority date | — |
| Expiry date | Feb 17, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2511/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.